Latest News and Press Releases

Want to stay updated on the latest news?

Sign into Reader Account Create Reader Account

March 01, 2018 16:05 ET | Source: OPKO Health, Inc.

OPKO Health Reports 2017 Fourth Quarter Business Highlights and Financial Results

MIAMI, March 01, 2018 (GLOBE NEWSWIRE) -- OPKO Health, Inc. (NASDAQ:OPK) reports business highlights and financial results for the three months ended December 31, 2017. Business Highlights ...
February 26, 2018 16:05 ET | Source: OPKO Health, Inc.

OPKO Health to Announce Fourth Quarter and Year End 2017 Financial Results on March 1, 2018

MIAMI, Feb. 26, 2018 (GLOBE NEWSWIRE) -- OPKO Health, Inc. (NASDAQ:OPK), plans to announce its operating and financial results for the three and twelve months ended December 31, 2017, after the...
January 26, 2018 08:00 ET | Source: OPKO Health, Inc.

OPKO Health Announces Leadership Changes at BioReference Laboratories

MIAMI, Jan. 26, 2018 (GLOBE NEWSWIRE) -- OPKO Health, Inc. (NASDAQ:OPK), announces that Gregory Henderson, M.D., Ph.D., has resigned from his position as President of BioReference Laboratories, an...
January 12, 2018 08:00 ET | Source: OPKO Health, Inc.

OPKO’S GeneDx Announces Research Collaboration with Radboud University Medical Center

MIAMI, Jan. 12, 2018 (GLOBE NEWSWIRE) -- OPKO Health, Inc. (NASDAQ:OPK), announces today that GeneDx, Inc., a subsidiary of OPKO’s BioReference Laboratories, has entered into a research...
November 27, 2017 11:02 ET | Source: OPKO Health, Inc.

OPKO Health Enrolls First Patient in Phase 2B Study of OPK88004 to Treat Benign Prostatic Hypertrophy

MIAMI, Nov. 27, 2017 (GLOBE NEWSWIRE) -- OPKO Health, Inc. (NASDAQ:OPK) (“OPKO” or “the Company”), announces that the Company has enrolled the first patient in a Phase 2b dose ranging trial of...
November 08, 2017 16:05 ET | Source: OPKO Health, Inc.

OPKO Health Reports 2017 Third Quarter Highlights and Financial Results

RAYALDEE total prescriptions increased 66% in Q3 2017 compared with Q2 20174Kscore utilization increased 19% in Q3 2017 compared with Q3 2016 4Kscore TV ads in the Northeast to begin November...
November 07, 2017 08:00 ET | Source: OPKO Health, Inc.

OPKO Health Submits Premarket Approval Application with FDA for a Point-of-Care PSA Test with the Claros® 1 Platform

MIAMI, Nov. 07, 2017 (GLOBE NEWSWIRE) -- OPKO Health, Inc. (NASDAQ:OPK) ("OPKO" or "the Company") announces the filing of a Premarket Approval (PMA) application with the U.S. Food and Drug...
November 03, 2017 09:43 ET | Source: OPKO Health, Inc.

OPKO Health to Announce 2017 Third Quarter Financial Results on November 8, 2017

MIAMI, Nov. 03, 2017 (GLOBE NEWSWIRE) -- OPKO Health, Inc. (NASDAQ:OPK) plans to announce its operating and financial results for the three and nine months ended September 30, 2017, after the close...
October 26, 2017 10:18 ET | Source: OPKO Health, Inc.

OPKO Health Licensee TESARO Announces FDA Approval of VARUBI® IV for Delayed Nausea and Vomiting Associated with Chemotherapy

MIAMI, Oct. 26, 2017 (GLOBE NEWSWIRE) -- OPKO Health, Inc. (NASDAQ:OPK) announces that its licensee, TESARO, Inc. (Nasdaq:TSRO), received U.S. Food and Drug Administration (FDA) approval for...
October 12, 2017 08:00 ET | Source: OPKO Health Inc.

OPKO Health Enters into Exclusive Agreement with Japan Tobacco to Develop and Commercialize RAYALDEE® in Japan

MIAMI, Oct. 12, 2017 (GLOBE NEWSWIRE) -- OPKO Health, Inc. (NASDAQ:OPK) announced that its subsidiary EirGen Pharma has entered into an exclusive agreement with Japan Tobacco Inc. (JT) for the...